US Broker Ratings

Abivax SA (ABVX) Stock Analysis: A Biotech Contender with 81% Potential Upside

Abivax SA (ABVX), a France-based biotechnology firm, is making waves in the healthcare sector with its promising pipeline and strategic focus on chronic inflammatory diseases. Despite..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A 131% Potential Upside in Biotech Innovation

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) stands out as an intriguing player in the biotechnology sector, particularly for investors with a keen eye on the burgeoning field..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: A Biotech Pioneer Facing Challenging Financial Metrics

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) stands at the forefront of synthetic biology, crafting a platform designed to revolutionize cell engineering. Operating primarily within the healthcare..

Celcuity Inc. (CELC) Stock Analysis: Exploring a 135.92% Potential Upside in the Biotech Arena

For investors with an eye on the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents a compelling case. With its focus on innovative targeted therapies for treating..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a 50% Potential Upside in the Biotech Sector

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector with its innovative approach to drug discovery, particularly in targeted oncology and genetic diseases. Headquartered..

Autolus Therapeutics (AUTL) Stock Analysis: Unpacking a 452% Potential Upside in Biotech Innovation

Autolus Therapeutics plc (NASDAQ: AUTL), a London-based biopharmaceutical innovator, is making waves in the healthcare sector with its promising pipeline of T cell therapies targeting cancer..

Inventiva S.A. (IVA): Consensus Shows 322% Upside Potential Amid Biotech Breakthroughs

Investors with a penchant for high-risk, high-reward opportunities should keep a close eye on Inventiva S.A. (NASDAQ: IVA), a promising player in the biotechnology sector. Headquartered..

Kamada Ltd. (KMDA) Stock Analysis: Unveiling a Potential 74.64% Upside in Healthcare

Kamada Ltd. (NASDAQ: KMDA) is capturing the attention of investors with its promising potential for growth in the healthcare sector. Specializing in plasma-derived protein therapeutics, the..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Unlocking an 80% Upside Potential

Investors eyeing biotechnology stocks with significant growth potential may want to consider Stoke Therapeutics, Inc. (NASDAQ: STOK). A key player in the healthcare sector, Stoke Therapeutics..

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Gem with 32.64% Potential Upside

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, is capturing investor attention with its robust growth potential and promising pipeline of G protein-coupled receptor (GPCR) therapies...

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: A 50% Upside Potential Amid Innovative Drug Development

For investors with a keen eye on the healthcare sector, Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) presents a fascinating opportunity, primarily due to its strong buy ratings..

AtaiBeckley Inc. (ATAI) Stock Analysis: Exploring the 137% Revenue Growth and Strategic Position in the Biotechnology Sector

AtaiBeckley Inc. (ATAI) is making waves in the biotechnology sector with a remarkable 137% revenue growth, capturing the attention of investors seeking high-potential opportunities in the..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: A Look at Its Stable Valuation Amidst Transformative Changes

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) finds itself in a unique position within the biotechnology sector, providing investors with an intriguing narrative. As a company specializing in..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth in Cancer Genomics Despite Financial Challenges

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector specializing in diagnostics and research, has captured attention with its innovative approach in the realm..

Bicycle Therapeutics (BCYC) Stock Analysis: Exploring a Potential 161% Upside Opportunity

Bicycle Therapeutics plc (NASDAQ: BCYC), a United Kingdom-based biotechnology company, is capturing attention in the healthcare sector, notably for its innovative approach to drug development through..

EyePoint, Inc. (EYPT) Stock Analysis: A Biotech with Massive 1,870% Upside Potential

EyePoint, Inc. (NASDAQ: EYPT), a biotechnology company focused on innovative treatments for serious retinal diseases, presents a fascinating opportunity for investors seeking high-risk, high-reward plays in..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Biotech Innovator with 452% Upside Potential

Sionna Therapeutics, Inc. (NASDAQ:SION) is capturing the attention of investors with its promising pipeline in the biotechnology sector, particularly in treating cystic fibrosis (CF). Despite its..

Dianthus Therapeutics, Inc. (DNTH) Investor Outlook: A 79% Upside Potential in the Biotech Sector

Dianthus Therapeutics, Inc. (DNTH), a promising player in the biotechnology sector, is capturing investor attention with its robust pipeline focused on combating severe autoimmune diseases. With..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Biotechnology Innovator Eyes 74% Upside

Keros Therapeutics, Inc. (NASDAQ: KROS), a dynamic player in the healthcare sector, is making waves in the biotechnology industry with its focus on innovative treatments for..

LENZ Therapeutics, Inc. (LENZ)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds